Disease Burden and Treatment Patterns in Patients Diagnosed With HER2- Metastatic Gastric/Gastroesophageal Junction Cancer (mG/GEJC)
07:30am - 03:45pm EDT - April 1, 2023
07:30am - 03:45pm EDT - April 1, 2023
Author(s):
- Dr Cassandra M. Matney, MD, Medical Director, Oncology, Astellas Pharma
Tags: Member Institution Outcomes and Health Services Research
| Display Label | Action |
|---|---|
| STZO015 HEOR_NCCN Congress Poster_FINAL_24Feb23.pdf | Download Handout |
| AC23P100 - Disease Burden and Treatment Patterns in Patients Diagnosed With HER2- Metastatic Gastric/Gastroesophageal Junction Cancer (mG/GEJC) | Download MP3 |
